drugset / Trial / NCT02412904
Randomized Controlled Trial Comparing Embryonic Quality in rFSH Versus hMG in IVF Protocol With GnRH Antagonist
Phase 4
Completed
188 enrolled
Hospital de Clinicas de Porto Alegre
Center for Human Reproduction · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
rFSH and HMG are both used to controlled ovarian stimulation for patients submitted to IVF. However, there is a debate in the literature which one is better to induce ovulation in patients receiving GnRH antagonist to block premature Luteinizing Hormone (LH) secretion. The investigators propose a Randomized Clinical Trial (RCT) to investigate the differences among recombinant FSH and HMG in patients submitted to IVF using GnRH antagonists.
Timeline
- Start
- 2014-01
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Recombinant Follicle Stimulating Hormone | Protein / enzyme biologic | 150 iu | — |
| Subject | Recombinant Follicle Stimulating Hormone | Protein / enzyme biologic | 300 iu | — |
| Subject | human menopause gonadotropin | Protein / enzyme biologic | 150 iu | — |
| Subject | human menopause gonadotropin | Protein / enzyme biologic | 300 iu | — |